Midas Pharma

Midas Pharma is a privately-held, revenue-generating service provider and supplier to the global pharmaceutical industry. Its core business model is built on offering integrated solutions from early-stage R&D to commercial launch, encompassing chemical and API supply, contract development and manufacturing (CDMO services), and regulatory and quality support. With a global network of affiliates, the company positions itself as a one-stop-shop for pharmaceutical and biotech companies seeking to outsource parts of their value chain. Its recent activities, such as the Biofidus partnership for integrated biotech solutions, indicate a strategic focus on expanding capabilities in the growing biopharmaceutical market.

Integrated pharmaceutical services and supply chain platform encompassing global sourcing, contract development & manufacturing (CDMO), regulatory/quality services, and biopharma partnering support.

Midas Pharma competes in the crowded global CDMO and pharmaceutical services market against large players like Lonza, Catalent, and Thermo Fisher Scientific, as well as numerous specialized regional and niche service providers. Its differentiation is its broad, integrated 'one-stop-shop' approach across the value chain.